# Synchron Stentrode: robot model

Canonical ID: `b1b7a2ef-267c-4571-a478-e999c75a5560`

- **Slug:** synchron-stentrode
- **Form factor:** wearable
- **Maturity stage:** pilot
- **Lifecycle:** active
- **Deployments registered:** 0

## Deployments

_No deployments registered for this model._

## Supply chain

_No verified supply relationships on file. Supply-chain coverage is being added across the registry; check back as the seed populates this model's suppliers._

_Suppliers appear when verified with at least two strong sources. Sources are append-only; corrections add new sources rather than rewrite history._

## Common questions

### What is Synchron Stentrode?

The Synchron Stentrode is an endovascular brain-computer interface implant that does not require open-brain surgery. Implanted via the jugular vein, it detects brain signals to enable patients with severe paralysis (ALS) to communicate via thought. The Stentrode has been tested in COMMAND (US) and SWITCH (Australia) clinical trials with no serious device-related adverse events.

### Who makes Synchron Stentrode?

Synchron Stentrode is made by Synchron, based in New York, NY, USA, founded in 2016.

### Where is Synchron Stentrode deployed?

No verified deployments of Synchron Stentrode are currently on the DEPLOY registry. DEPLOY records deployments only when verified at a named site with a primary source; absence may reflect pre-deployment, research, or manufacturer-internal use.

### What is Synchron Stentrode's maturity stage?

Synchron Stentrode is at the pilot stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Pilot stage means at least one named-customer trial deployment is verified.


## Sources (1)

1. https://evtoday.com/news/synchrons-brain-computer-interface-evaluated-in-command-early-feasibility-study

_API: GET /v1/models/b1b7a2ef-267c-4571-a478-e999c75a5560 · canonical URL: /models/synchron-stentrode_